|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||81.30 - 81.30|
|52 Week Range||60.50 - 91.55|
|Beta (3Y Monthly)||0.40|
|PE Ratio (TTM)||30.29|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
BIOMERIEUX (BMXMF) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
bioMérieux SA (EPA:BIM) shareholders, and potential investors, need to understand how much cash the business makes from its core operational activities, as well as how much is invested back intoRead More...
European stocks were lower Wednesday afternoon, as renewed concerns over international trade conflicts hampered investors' appetite for riskier assets.
Investors with a long-term horizong may find it valuable to assess bioMérieux SA’s (EPA:BIM) earnings trend over time and against its industry benchmark as opposed to simply looking at aRead More...